Skip to content

Our Anesthesia Experiences in Hepatopancreatobiliary Surgery Practices: a Retrospective Study

Our Anesthesia Experiences in Hepatopancreatobiliary Surgery Practices: a Retrospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06002776
Enrollment
6
Registered
2023-08-21
Start date
2023-08-31
Completion date
2023-09-30
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Experience, Life

Keywords

major abdominal surgery, Revised Cardiac Risk Index, Epidural analgesia, perioperative fluid management, ERAS protocols

Brief summary

Has the evolving anesthetic management in major abdominal surgeries had a positive impact on patients' one-year postoperative mortality and length of hospital stay? Which of the anesthetic management parameters have influenced mortality and hospital stay duration in these patients? To address these questions, we have planned to retrospectively review patients who underwent surgery at our center.

Detailed description

In our study, we aimed to compile our practices over the last 5 years by evaluating the impact of perioperative and postoperative anesthetic management on morbidity and mortality in hepatopancreatobiliary surgical patients. Our primary outcome was to form a comprehensive understanding of our anesthesia experiences during the preoperative, perioperative, and postoperative periods in this patient group. Our secondary outcome was to assess the influence of preoperative and perioperative anesthetic management on the morbidity and mortality of these patients.

Interventions

OTHERa retrospective study

a retrospective study

Sponsors

Sisli Hamidiye Etfal Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The study will include data from patients who have undergone their first operation with the diagnoses of liver malignancy, cholangiocarcinoma, and pancreatic malignancy during the period from October 2017 to February 2022.

Exclusion criteria

* Data from patients who were deemed inoperable during the perioperative period after being taken into surgery with their current diagnosis, as well as data from patients who underwent repeat operations, were excluded from the study for their second and subsequent hospitalizations.

Design outcomes

Primary

MeasureTime frame
form a comprehensive understanding of our anesthesia experiences during the preoperative, perioperative, and postoperative periods in this patient groupoctober2017-february2022

Secondary

MeasureTime frame
assess the influence of preoperative and perioperative anesthetic management on the morbidity and mortality of these patients.october2017-february2022

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026